Amryt Pharmaceuticals Inc.
Records under this name other than the patents Amryt Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 36 patents it holds.
Back to Amryt Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,828,444 | Triterpene-Containing Oleogel-Forming Agent, Triterpene-Containing Oleogel and Method for Producing a Triterpene-Containing Oleogel Term ended Term ended Jun 21, 2025 · Medium confidence | Term ended | Term ended Jun 21, 2025 | Medium confidence |
| US 7,482,383 | Emulsion Containing a Plant Extract, Method for Producing Said Emulsion and for Obtaining Said Plant Extract Term ended Term ended Mar 26, 2021 · High confidence | Term ended | Term ended Mar 26, 2021 | High confidence |
| 10/239,929 | Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract Abandoned Abandoned May 29, 2007 | Abandoned | Abandoned May 29, 2007 | |
| 15/792,277 | Use of an Oleogel Containing Triterpene for Healing Wounds Abandoned Abandoned Apr 29, 2019 | Abandoned | Abandoned Apr 29, 2019 | |
| 15/882,919 | Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity Abandoned Abandoned Jul 3, 2021 | Abandoned | Abandoned Jul 3, 2021 | |
| 16/010,995 | Use of an Oleogel Containing Triterpene for Healing Wounds Abandoned Abandoned Feb 26, 2021 | Abandoned | Abandoned Feb 26, 2021 | |
| 16/318,805 | Betulin-Containing Water-In-Oil Foams and Compositions Thereof Abandoned Abandoned Mar 2, 2021 | Abandoned | Abandoned Mar 2, 2021 | |
| 16/959,098 | Betulin-Containing Birch Bark Extracts and Their Formulation Abandoned Abandoned Aug 9, 2023 | Abandoned | Abandoned Aug 9, 2023 | |
| 17/418,067 | Methods for Forming Polyplexes now held by Amryt Genetics Ltd. Abandoned Abandoned Nov 18, 2024 | Abandoned | Abandoned Nov 18, 2024 | |
| 18/018,031 | Lomitapide for Use in Methods of Treating Hyperlipidemia and Hypercholesterolemia in Pediatric Patients Abandoned Abandoned Jan 6, 2024 | Abandoned | Abandoned Jan 6, 2024 |